Comparison

Fibrinopeptide A, human

Item no. AS-20735
Manufacturer AnaSpec
CASRN 25422-31-5
Amount 1 mg
Category
Type Peptides
Format Lyophilized
Specific against other
Conjugate/Tag Unconjugated
Purity Peak Area by HPLC ≥95%
Sequence H-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg-OH
Citations Eisenberg, PR. et al. Circ. 71(5):912-918, (1985).
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ADSGEGDFLAEGGGVR
Shipping Condition Room temperature
Available
Manufacturer - Category
Catalog Peptides / Catalog Peptides Gr / Peptides
Manufacturer - Targets
Fibrinopeptide
Shipping Temperature
RT
Storage Conditions
- 20 °C
Molecular Weight
1536.7
Manufacturer - Research Area
Cardiovascular Research / Coagulation
Description
Fibrinopeptides A and B (FPA and FPB) are short amino acid sequences located at the N-terminus of fibrinogen A and B, respectively. Fibrinopeptide A is a 16-amino acid cleavage product induced by thrombin. Together with Fibrinopeptide B, it uncovers the E domain of fibrinogen. The residual protein, fibrin monomer, polymerizes to form fibrin clot. Thus, liberation of approximately 4 ng/ml of FPA per milligram of fibrinogen is closely linked to clot formation. Because proteolysis of fibrinogen accelerates early after the onset of thrombosis, marked elevations in FPA levels are expected early after the onset of clotting. Elevation of Fibrinopeptide A levels in plasma is seen in association with disorders such as disseminated intravascular coagulation, deep venous thrombosis, arterial thrombosis, and malignancy. Given the short half-life of FPA in plasma (3-5 min) and the conversion of fibrinogen to fibrin is particularly rapid and early during the course of thrombosis, measuring for elevated FPA levels in samples obtained very early after the onset of symptoms of transmural infarction would be beneficial to assess association with acute coronary thrombosis. Elevated FPA levels appear to be a marker during the course of coronary thrombosis .
Sequence One-Letter Code
ADSGEGDFLAEGGGVR
Post Synthesis Coupling
No
Usage
Research use
UNSPSC
12352202
GTIN
5400535053963

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close